ZonMw funding of 750,000 euros for Targeting the Mesenchymal Cancer Cell Phenotype for Therapeutic Gain

ZonMw funding of 750,000 euros for Targeting the Mesenchymal Cancer Cell Phenotype for Therapeutic Gain

Prof Peter ten Dijke (LUMC), dr. Pouyan Boukany (TU Delft), Prof John Martens (Erasmus MC) and Prof Stefan Sleijfer (Erasmus MC) aim to identify and repurpose existing drugs to selectively change the behaviour of aggressive cancer cells into non-invasive and therapy sensitive cancer cells or benign fat cells.

Full information: NL : EN

Collaborate with us

Looking for information on one of our topics, a new place to conduct your research or experienced research to join forces with?  Feel free to contact us.!

Read more